Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2020 | 06-2019 | 06-2017 | 06-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 5,806 | 9,837 | N/A | N/A |
| Marketable Securities | 42 | 3,947 | N/A | N/A |
| Receivables | 45 | 65 | N/A | N/A |
| TOTAL | $6,313 | $14,173 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 404 | 43 | N/A | N/A |
| Intangibles | 1,087 | 1,221 | 0 | 0 |
| TOTAL | $1,490 | $1,264 | $N/A | $N/A |
| Total Assets | $7,803 | $15,437 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,607 | 1,194 | 0 | 0 |
| TOTAL | $1,676 | $1,194 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $248 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,924 | $1,194 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 53,065 | 53,065 | N/A | N/A |
| Retained earnings | -64,649 | -55,710 | N/A | N/A |
| Other shareholders' equity | -302 | 118 | 0 | 0 |
| TOTAL | $5,878 | $14,243 | $N/A | $N/A |
| Total Liabilities And Equity | $7,803 | $15,437 | $0 | $0 |